James P. Flynn

ORCID: 0000-0002-8663-5087
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • Chemical Thermodynamics and Molecular Structure
  • Carbohydrate Chemistry and Synthesis
  • Chemical Synthesis and Analysis
  • Library Science and Information Literacy
  • Biosensors and Analytical Detection
  • Disaster Response and Management
  • Tuberculosis Research and Epidemiology
  • COVID-19 epidemiological studies
  • Long-Term Effects of COVID-19
  • Sulfur-Based Synthesis Techniques
  • Proteoglycans and glycosaminoglycans research
  • vaccines and immunoinformatics approaches
  • Web and Library Services
  • Global Health Workforce Issues
  • Advanced biosensing and bioanalysis techniques
  • Click Chemistry and Applications
  • Material Properties and Applications
  • Respiratory viral infections research
  • Primary Care and Health Outcomes
  • Risk and Safety Analysis
  • Thermal and Kinetic Analysis

Brigham and Women's Hospital
2021-2024

Harvard University
2021-2024

Boston College
2018-2023

Catholic Medical Center
2020

John Wiley & Sons (United Kingdom)
2012

University of Maryland Medical System
1992-2007

University Hospital Lewisham
2003

University of Delaware
2003

University of Maryland, Baltimore
1992

National Tuberculosis Institute
1988

We enrolled 7 individuals with recurrent symptoms or antigen test conversion following nirmatrelvir-ritonavir treatment. High viral loads (median 6.1 log10 copies/mL) were detected after rebound for a median of 17 days initial diagnosis. Three had culturable virus up to 16 No known resistance-associated mutations identified.

10.1093/cid/ciac512 article EN Clinical Infectious Diseases 2022-06-23

Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but the immune defects that predispose an individual to persistent disease 2019 (COVID-19) remain incompletely understood. In this study, we performed detailed viro-immunologic analyses of a prospective cohort participants with COVID-19. The median times nasal viral RNA culture clearance in immunosuppression due...

10.1126/scitranslmed.adk1599 article EN Science Translational Medicine 2024-01-24

The orthogonal sulfur-fluoride exchange reaction (SuFEx) and copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) are employed to synthesize sequence-regulated synthetic polymers. high efficiency broad tolerance of SuFEx CuAAC diverse chemical functionalities enable the one-pot synthesis polydispersed sequence-controlled polymers by step-growth copolymerization in yield sequence complexity. Furthermore, iterative coupling reactions on a solid support, without need protecting groups, afford...

10.1002/anie.201811051 article EN Angewandte Chemie International Edition 2018-10-16

There is limited information on the specific impact of maternal infection with SARS-CoV-2 B.1.617.2 (delta) variant pregnancy outcomes. We present 2 cases intrauterine fetal demise and 1 case severe distress in setting delta-variant SARS-CoV-2. In all cases, or occurred within 14 days COVID-19 diagnosis. Evaluation revealed viremia, high nasopharyngeal viral load, evidence placental SARS-CoV-2, hallmark features placentitis. suggest that during warrants vigilance for dysfunction compromise...

10.1093/infdis/jiac008 article EN The Journal of Infectious Diseases 2022-01-11

Isolation guidelines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are largely derived from data collected prior to the emergence of delta variant. We followed a cohort ambulatory patients with postvaccination breakthrough SARS-CoV-2 infections longitudinal collection nasal swabs viral load quantification, whole-genome sequencing, and culture. All variant in our were symptomatic, compared 64% non-delta infections. Symptomatic characterized by higher initial load, longer...

10.1172/jci.insight.155483 article EN cc-by JCI Insight 2021-12-06

Clinical features of SARS-CoV-2 Omicron variant infection, including incubation period and transmission rates, distinguish this from preceding variants. However, whether the duration shedding viable virus differs between omicron previous variants is not well understood. To characterize how vaccination status impact virus, we serially sampled symptomatic outpatients newly diagnosed with COVID-19. Anterior nasal swabs were tested for viral load, sequencing, culture. Time to PCR conversion was...

10.1101/2022.03.01.22271582 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-03-02

Abstract O‐sulfation is an important chemical code widely existing in bioactive molecules, but the scalable and facile synthesis of complex molecules carrying O‐sulfates remains challenging. Reported here a general approach to by sulfur(VI) fluoride exchange (SuFEx) reaction between aryl fluorosulfates silylated hydroxy groups. Efficient sulfate diester formation was achieved through systematic optimization electronic properties fluorosulfates. The versatility this strategy demonstrated...

10.1002/anie.202007211 article EN Angewandte Chemie International Edition 2020-07-09

Protective immunity against SARS-CoV-2 infection after COVID-19 vaccination may differ by variant. We enrolled vaccinated (n = 39) and unvaccinated 11) individuals with acute, symptomatic Delta or Omicron performed viral load quantification, whole-genome sequencing, variant-specific antibody characterization at the time of acute illness convalescence. Viral was inversely correlated binding neutralizing responses. Across all variants tested, convalescent neutralization titers in were markedly...

10.1172/jci.insight.159944 article EN cc-by JCI Insight 2022-10-09

We assessed the ability of BinaxNow rapid test to detect severe acute respiratory syndrome coronavirus 2 antigen from 4 individuals with Omicron and Delta infections. performed serial dilutions nasal swab samples, specimens concentrations ≥100 000 copies/swab were positive, demonstrating that is able variant.

10.1093/ofid/ofac022 article EN cc-by-nc-nd Open Forum Infectious Diseases 2022-01-28

Abstract The orthogonal sulfur–fluoride exchange reaction (SuFEx) and copper(I)‐catalyzed azide–alkyne cycloaddition (CuAAC) are employed to synthesize sequence‐regulated synthetic polymers. high efficiency broad tolerance of SuFEx CuAAC diverse chemical functionalities enable the one‐pot synthesis polydispersed sequence‐controlled polymers by step‐growth copolymerization in yield sequence complexity. Furthermore, iterative coupling reactions on a solid support, without need protecting...

10.1002/ange.201811051 article EN Angewandte Chemie 2018-10-16

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTThermochemistry of the Rare Earths. II. Lanthanum, Praseodymium, Samarium, Gadolinium, Erbium, Ytterbium and YttriumF. H. Spedding J. P. FlynnCite this: Am. Chem. Soc. 1954, 76, 6, 1474–1477Publication Date (Print):March 1, 1954Publication History Published online1 May 2002Published inissue 1 March 1954https://pubs.acs.org/doi/10.1021/ja01635a004https://doi.org/10.1021/ja01635a004research-articleACS PublicationsRequest reuse permissionsArticle...

10.1021/ja01635a004 article EN Journal of the American Chemical Society 1954-03-01

Abstract The impact of coronavirus disease 2019 vaccination on viral characteristics breakthrough infections is unknown. In this prospective cohort study, incidence severe acute respiratory syndrome 2 infection decreased following vaccination. Although asymptomatic positive tests were observed vaccination, the higher cycle thresholds, repeat negative tests, and inability to culture virus raise questions about their clinical significance.

10.1093/cid/ciab643 article EN Clinical Infectious Diseases 2021-07-21

Abstract There is increasing evidence that the risk of SARS-CoV-2 infection among vaccinated individuals variant-specific, suggesting protective immunity against may differ by variant. We enrolled (n = 39) and unvaccinated 11) with acute, symptomatic Delta or Omicron performed viral load quantification, whole-genome sequencing, variant-specific antibody characterization at time acute illness convalescence. Viral was inversely correlated binding neutralizing responses. Increases in titers...

10.1101/2022.03.02.22271731 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-03-03

Persistent SARS-CoV-2 replication and systemic dissemination are linked to increased COVID-19 disease severity mortality. However, the precise immune profiles that track with enhanced viral clearance, particularly from RNAemia, remain incompletely defined. To define whether antibody characteristics, specificities, or functions emerge during natural infection accelerated containment of replication, we examined relationship SARS-CoV-2-specific humoral evolution in setting plasma which is...

10.1128/mbio.01577-22 article EN cc-by mBio 2022-06-28

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTIntegral Heats of Solution Some Rare Earth TrichloridesF. H. Spedding and J. P. FlynnCite this: Am. Chem. Soc. 1954, 76, 6, 1477–1480Publication Date (Print):March 1, 1954Publication History Published online1 May 2002Published inissue 1 March 1954https://pubs.acs.org/doi/10.1021/ja01635a005https://doi.org/10.1021/ja01635a005research-articleACS PublicationsRequest reuse permissionsArticle Views94Altmetric-Citations20LEARN ABOUT THESE METRICSArticle...

10.1021/ja01635a005 article EN Journal of the American Chemical Society 1954-03-01

Resistance mutations to monoclonal antibody (mAb) therapy has been reported, but in the non-immunosuppressed population, it is unclear if vivo emergence of SARS-CoV-2 resistance alters either viral replication dynamics or therapeutic efficacy. In ACTIV-2/A5401, non-hospitalized participants with symptomatic infection were randomized bamlanivimab (700mg 7000mg) placebo. Treatment-emergent significantly more likely detected after 700mg treatment than placebo (7% 111 vs 0% 112 participants,...

10.1101/2021.09.03.21263105 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-09-15

Abstract We enrolled seven individuals with recurrent symptoms following nirmatrelvir-ritonavir treatment. High viral loads (median 6.1 log 10 copies/mL) were detected at enrollment and for a median of 17 days after initial diagnosis. Three had culturable virus up to 16 No known resistance-associated mutations identified.

10.1101/2022.05.24.22275326 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2022-05-26

Abstract Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for prolonged SARS-CoV-2 infection, but the immune defects that predispose to persistent COVID-19 remain incompletely understood. In this study, we performed detailed viro-immunologic analyses of a prospective cohort participants with COVID-19. The median time nasal viral RNA culture clearance in severe hematologic malignancy/transplant group (S-HT) were 72 40 days, respectively, which...

10.1101/2023.07.31.23293441 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2023-08-02

Abstract Background Monoclonal antibodies (mAbs) represent a crucial antiviral strategy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but it is unclear whether combination mAbs offer benefit over single-active mAb treatment. Amubarvimab and romlusevimab significantly reduced the risk of hospitalizations or death in ACTIV-2/A5401 trial. Certain SARS-CoV-2 variants are intrinsically resistant against romlusevimab, leading to only therapy with amubarvimab these...

10.1093/infdis/jiae192 article EN The Journal of Infectious Diseases 2024-05-08

Abstract Widespread, frequent testing is essential for curbing the ongoing COVID-19 pandemic. Because its simplicity makes it ideal widely distributed, high throughput testing, RT-LAMP provides an attractive alternative to RT-qPCR. However, most protocols require purification of RNA, a complex and low-throughput bottleneck that has often been subject reagent supply shortages. Here, we report optimized RT-LAMP-based SARS-CoV-2 diagnostic protocol saliva swab samples. In replace RNA with...

10.1101/2020.11.19.20234948 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2020-11-22
James Regan James P. Flynn Alexandra Rosenthal Hannah Jordan Yijia Li and 95 more Rida Chishti Françoise Giguel Heather Corry Kendyll Coxen Jesse Fajnzylber Elizabeth Gillespie Daniel R. Kuritzkes Nir Hacohen Marcia B. Goldberg Michael R. Filbin Xu G. Yu Lindsey R. Baden Ruy M. Ribeiro Alan S. Perelson Jessica M. Conway Jonathan Z. Li Betelihem A. Abayneh Patrick Allen Galit Alter Diane Antille Katrina Armstrong Alejandro B. Balazs Julia Bals Max Barbash Yannic C. Bartsch Julie Boucau Siobhan Boyce Joan Braley Kelley R. Branch Katherine Broderick Julia Carney Andrew Chan Joshua M Chevalier Fatema Z. Chowdhury George Q. Daley Susan Davidson Michael Dougan David Drew Kevin Einkauf Ashley Elliman Jon Fallon Liz Fedirko Kelsey Finn Keith T. Flaherty Jeanne Flannery Pamela J. Forde Pilar García‐Broncano Elise Gettings David Golan Amanda Griffin Sheila Grimmel Kathleen Grinke Kathryn Hall Ciputra Adijaya Hartana Meg Healy Howard M. Heller Deborah Henault Grace Holland Chenyang Jiang Nikolaus Jilg Paulina Kapłonek Marshall Karpell Chantal Kayitesi Evan C. Lam Vlasta LaValle Kristina Lefteri Xiaodong Lian Mathias Lichterfeld Daniel Lingwood Hang Liu Jin-Qing Liu Yiting Lu Sarah Luthern Natasha Ly Jordan Marchewka Britanni Martino Roseann McNamara Ashlin R. Michell Ilan Millstrom Noah Miranda Christian Nambu Susan C. Nelson Marjorie Noone Claire O’Callaghan Christine Ommerborn Mathew Osborn Lois Chris Pacheco Nicole Phan Shiv Pillai Falisha A. Porto Yelizaveta Rassadkina Alexandra Reissis Alex Rosenthal Francis F. Ruzicka Edward T. Ryan

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) kinetics remain understudied, including the impact of remdesivir. In hospitalized individuals, peak sputum viral load occurred in week symptoms, whereas viremia peaked within 1 symptom-onset, suggesting early systemic seeding SARS-CoV-2. Remdesivir treatment was associated with faster decay.

10.1093/ofid/ofab153 article EN cc-by-nc-nd Open Forum Infectious Diseases 2021-04-17
Coming Soon ...